The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...

The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...

Recent discoveries and advances in pharma for lower demand illnesses/indications ... knowledge and provide our clients with end-to-end solutions that meet their needs. Safety, quality, and ...

The pharma group’s chief executive, David Ricks, has told the Financial Times that the authorities should examine the deal closely, given that Catalent’s client roster includes “in excess of ...

Nanomedicine holds immense promise for revolutionizing healthcare. By manipulating materials at the nanoscale, researchers ...

In an increasingly complex pharmaceutical landscape, companies face significant challenges in bringing their products from ...

GlobalCapital is delighted to reveal the winners of the Syndicated Loan, Leveraged Finance and Private Debt Awards 2024.

Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, with Barcelona at the center of its success.

Pete Marocco, deputy administrator-designate at the U.S. Agency for International Development (USAID), arrives to meet with members of Congress to discuss foreign assistance, on Capitol Hill in ...

John Chiminski brings more than three decades of leadership in healthcare and pharma services. He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as ...